Also trades as: 4887.T (JPX) · $vol 6M

$11.52

+0.00 (+0.00%)

OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 50 · $1.3B mcap · 105M float · 0.0001% daily turnover · Short 100% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

Income Trends

Revenue

$202.9B +7.4% ▲

5Y CAGR: +1.6%

Gross Profit

$59.2B +5.0% ▲

5Y CAGR: -4.0%

Operating Income

$20.5B -1.6% ▼

5Y CAGR: +1.6%

Net Income

$10.5B -54.2% ▼

5Y CAGR: -3.2%

EPS (Diluted)

$91.07 -50.6% ▼

5Y CAGR: -20.2%

EBITDA

$36.6B +1.1% ▲

5Y CAGR: -2.4%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$193.8B	$200.3B	$176.9B	$189.0B	$202.9B
YoY Growth	+3.5%	+3.4%	-11.7%	+6.9%	+7.4%
Cost of Revenue	$127.2B	$137.7B	$122.5B	$132.7B	$143.8B
Gross Profit	$66.7B	$62.6B	$54.3B	$56.4B	$59.2B
Gross Margin	34.4%	31.3%	30.7%	29.8%	29.2%
R&D Expenses	$24.4B	$16.1B	$12.2B	$12.6B	$12.5B
SG&A Expenses	$46.7B	$30.2B	$23.2B	$23.5B	$26.2B
Operating Expenses	$71.1B	$46.2B	$35.7B	$35.5B	$38.7B
Operating Income	-$4.5B	$16.4B	$18.6B	$20.8B	$20.5B
Operating Margin	-2.3%	8.2%	10.5%	11.0%	10.1%
Interest Expense	$471M	$398M	$558M	$1.0B	$1.8B
Income Before Tax	-$36.2B	$16.8B	$18.3B	$19.9B	$14.4B
Tax Expense	$5.7B	$4.0B	$5.6B	$6.8B	$2.8B
Net Income	-$28.3B	$12.7B	$13.7B	$22.9B	$10.5B
Net Margin	-14.6%	6.3%	7.7%	12.1%	5.2%
EPS (Diluted)	$-645.54	$96.20	$311.80	$184.45	$91.07
EBITDA	-$18.7B	$33.9B	$36.9B	$36.2B	$36.6B
Shares Outstanding	44M	44M	44M	124M	115M

Line Item	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3	FY2026 Q4
Revenue	$44.3B	$43.5B	$55.3B	$45.8B	$49.5B	$50.0B	$56.1B	$47.1B
Cost of Revenue	$30.3B	$30.2B	$37.4B	$34.7B	$34.1B	$35.5B	$39.0B	$35.1B
Gross Profit	$14.0B	$13.3B	$17.9B	$11.1B	$15.4B	$14.5B	$17.1B	$12.0B
Gross Margin	31.6%	30.6%	32.3%	24.3%	31.2%	29.0%	30.5%	25.5%
R&D Expenses	$2.4B	$3.0B	$2.4B	$4.8B	$2.4B	$2.9B	$3.6B	$3.6B
SG&A Expenses	$5.5B	$5.3B	$5.7B	$7.0B	$6.0B	$6.0B	$6.0B	$8.2B
Operating Expenses	$7.9B	$8.3B	$8.2B	$11.8B	$8.5B	$8.9B	$9.5B	$11.8B
Operating Income	$6.8B	$5.0B	$9.7B	-$665M	$7.0B	$5.6B	$7.6B	$245M
Operating Margin	15.3%	11.5%	17.6%	-1.5%	14.1%	11.3%	13.5%	0.5%
Interest Expense	$258M	$194M	$268M	$275M	$177M	$345M	$590M	$532M
Income Before Tax	$5.9B	$5.5B	$9.4B	-$941M	$6.8B	$1.2B	$6.8B	-$532M
Tax Expense	$1.9B	$1.7B	$3.0B	$222M	$1.9B	$7M	$2.0B	-$1.2B
Net Income	$15.5B	$3.4B	$6.6B	-$2.5B	$4.9B	$968M	$4.9B	-$313M
Net Margin	34.9%	7.8%	11.8%	-5.5%	9.9%	1.9%	8.8%	-0.7%
EPS (Diluted)	$353.54	$29.94	$53.04	$-9.98	$41.92	$8.36	$42.35	$-2.40
EBITDA	$9.7B	$9.6B	$13.6B	$3.3B	$10.8B	$1.5B	$7.6B	$245M
Shares Outstanding	44M	127M	121M	117M	116M	116M	116M	130M

SWGHF OTC

Income Trends

Profit Margins

Year-over-Year Growth

Sign in to InsiderStreet